Prevention

Viral Hepatitis

Volumn , Issue , 2007, Pages 635-648

  Purcell, Robert H ^a   Emerson, Suzanne U ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Epidemiology; Genetic variation; Geographic distribution; Hepatitis E virus (HEV) prevention; Immune response

Indexed keywords

EID: 33847372463     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987131.ch42     Document Type: Chapter

References (125)

1. Purcell RH, Emerson SU. Hepatitis E virus. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases, 6th edn. Philadelphia:Elsevier, 2005: 2204-17.
2. Szmuness W, Dienstag JL, Purcell RH et al. The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol 1977;106:392-8.
3. Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from posttransfusion non-A, non-B type. Am J Med 1980;68:818-24.
4. Wong DC, Purcell RH, Sreenivasan MA et al. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet 1980;2:876-9.
5. Balayan MS, Andjaparidze AG, Savinskaya SS et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecaloral route. Intervirology 1983;20:23-31.
6. Bradley DW. Hepatitis non-A, non-B viruses become identified as hepatitis C and E viruses. In: Melnick JL, ed. Progress in Medical Virology. Basel: Karger, 1990:101-35.
7. Purcell RH, Ticehurst JR. Enterically transmitted non-A, non-B hepatitis: epidemiology and clinical characteristics. Proceedings 1987 International Symposium on Viral Hepatitis and Liver Disease, London, May, 1987. In: Zuckerman A, ed. Viral Hepatitis and Liver Disease. New York: Alan R. Liss, 1988:131-7.
8. Reyes GR, Purdy MA, Kim JP et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990;247:1335-9.
9. Zuckerman AJ. Twenty-five centuries of viral hepatitis. Perspectives in viral hepatitis. Rush-Presbyterian-St. Luke’s Med Bull 1976;15:57-82.
10. Cockayne EA. Catarrhal jaundice, sporadic, and epidemic and its relation to acute yellow atrophy of the liver. Q J Med 1912;6:1-29.
11. Arankalle VA, Chobe LP. Hepatitis E: can it be transmitted parenterally? J Viral Hepat 1998;6:161-4.
12. Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 2004;19:778-84.
13. Mast EE, Alter MJ. Epidemiology of viral hepatitis: an overview. Semin Virol 1993;4:273-83.
14. Velazquez O, Stetler HC, Avila C et al. Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986-1987. JAMA 1990;263:3281-5.
15. Schlauder GG, Mushahwar IK. Genetic heterogeneity of hepatitis E virus. J Med Virol 2001;65:282-92.
16. Worm HC, van der Poel WH, Brandstatter G. Hepatitis E: an overview. Microbes Infect 2002;4:657-66.
17. Purcell RH, Emerson SU. Animal models of hepatitis A and E. ILAR J 2001;42:161-77.
18. Barker LF, Maynard JE, Purcell RH et al. Hepatitis B virus infection in chimpanzees: titration of subtypes. J Infect Dis 1975;132:451-8.
19. Purcell RH, Feinstone SM, Ticehurst JR et al. Hepatitis A virus. Proceedings 1984 Viral Hepatitis Symposium, San Francisco, California, March 8-10, 1984. In: Vyas GN, Dienstag J, Hoofnagle J, eds. Viral Hepatitis and Liver Disease. Orlando, FL: Grune & Stratton, 1984:9-22.
20. Tsarev SA, Tsareva TS, Emerson SU et al. Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys. J Med Virol 1994;43:135-42.
21. Balayan MS, Usmanov RK, Zamyatina NA et al. Experimental hepatitis E infection in domestic pigs. J Med Virol 1990;32:58-9.
22. Karetnyi YV, Dzhumalieva DI, Usmanov RK et al. Probable involvement of rodents in the spread of viral hepatitis E. Zh Mikrobiol Epidemiol Immunobiol 1993;4:52-6.
23. Maneerat Y, Clayson ET, Myint K et al. Experimental infection of the laboratory rat with the hepatitis E virus. J Med Virol 1996;48:121-8.
24. Usmanov RK, Balaian MS, Dvoinikova OV et al. Experimental infection of lambs with hepatitis E virus. Vopr Virusol 1994;39:165-8 [in Russian].
25. Meng XJ, Purcell RH, Halbur PG et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA 1997;94:9860-5.
26. Meng XJ, Halbur PG, Haynes JS et al. Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV. Arch Virol 1998;143:1405-15.
27. Meng XJ, Halbur PG, Shapiro MS et al. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol 1998;72:9714-21.
28. Lu L, Drobeniuc J, Kobylnikov N et al. Complete sequence of a Kyrgyzstan swine hepatitis E virus (HEV) isolated from a piglet thought to be experimentally infected with human HEV from Kyrgyzstan. J Med Virol 2004;74:556-62.
29. Matsuda H, Okada K, Takahashi K et al. Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar. J Infect Dis 2003;188:944.
30. Tei S, Kitajima N, Takahashi K et al. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003;362:371-3.
31. Yazaki Y, Mizuo H, Takahashi M et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J Gen Virol 2003;84:2351-7.
32. Kabrane-Lazizi Y, Fine JB, Elm J et al. Evidence for wide-spread infection of wild rats with hepatitis E virus in the United States. Am J Trop Med Hyg 1999;61:331-5.
33. Arankalle VA, Joshi MV, Kulkarni AM et al. Prevalence of antihepatitis E virus antibodies in different Indian animal species. J Viral Hepatol 2001;8:223-7.
34. Favorov MO, Kosoy MY, Tsarev SA et al. Prevalence of antibody to hepatitis E virus among rodents in the United States. J Infect Dis 2000;181:449-55.
35. Purcell RH, Rood M, Kabrane-Lazizi Y et al. Recovery of hepatitis E virus (HEV)-like agents from rats in Los Angeles [Abstract 56]. Am J Trop Med Hyg 2001;65(Suppl.)):153.
36. Huang FF, Haqshenas G, Shivaprasad HL et al. Heterogeneity and seroprevalence of a newly identified avian hepatitis e virus from chickens in the United States. J Clin Microbiol 2002;40:4197-202.
37. Payne CJ, Ellis TM, Plant SL et al. Sequence data suggests big liver and spleen disease virus (BLSV) is genetically related to hepatitis E virus. Vet Microbiol 1999;68:119-25.
38. Huang FF, Sun ZF, Emerson SU et al. Determination and analysis of the complete genomic sequence of avian hepatitis E virus (avian HEV) and attempts to infect rhesus monkeys with avian HEV. J Gen Virol 2004;85:1609-18.
39. Huang RT, Li DR, Wei J et al. Isolation and identification of hepatitis E virus in Xinjiang, China. J Gen Virol 1992;73:1143-8.
40. Meng XJ, Dubreuil P, Pillot J. A new PCR-based seroneutralization assay in cell culture for diagnosis of hepatitis E. J Clin Microbiol 1997;35:1373-7.
41. Emerson SU, Nguyen N, Graff J et al. In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein. J Virol 2004;78:4838-46.
42. Piper-Jenks N, Horowitz HW, Schwartz E. Risk of hepatitis E infection to travellers. J Travel Med 2000;7:194-9.
43. Mast EE, Alter MJ, Holland PV et al. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatology 1998;27:857-61.
44. Arankalle VA, Tsarev SA, Chadha MS et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis 1995;171:447-50.
45. Meng XJ, Wiseman B, Elvinger F et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002;40:117-22.
46. Thomas DL, Yarbough PO, Vlahov D et al. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 1997;35:1244-7.
47. Fix AD, Abdel-Hamid M, Purcell RH et al. Prevalence of antibodies to hepatitis E in two rural Egyptian communities. Am J Trop Med Hyg 2000;62:519-23.
48. Clemente-Casarea P, Pina S, Buti M et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis 2003;9:448-54.
49. Pina S, Buti M, Cotrina M et al. HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain. J Hepatol 2000;33:826-33.
50. Vaidya SR, Chitambar SD, Arankalle VA. Polymerase chain reaction-based prevalence of hepatitis A, hepatitis E and TT viruses in sewage from an endemic area. J Hepatol 2002;37:131-6.
51. Halbur PG, Kasorndorkbua C, Gilbert C et al. Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human. J Clin Microbiol 2001;39:918-23.
52. Clayson ET, Vaughn DW, Innis BL et al. Association of hepatitis E virus with an outbreak of hepatitis at a military training camp in Nepal. J Med Virol 1998;54:178-82.
53. Clayson ET, Shrestha MP, Vaughn DW et al. Rates of hepatitis E virus infection and disease among adolescents and adults in Kathmandu, Nepal. J Infect Dis 1997;176:763-6.
54. Fabrizi F, Martin P. Hepatitis E in end-stage renal disease [editorial]. Int J Artif Organs 1999;22:593-9.
55. Drobeniuc J, Favorov MO, Shapiro CN et al. Hepatitis E virus antibody prevalence among persons who work with swine. J Infect Dis 2001;184:1594-7.
56. Cacopardo B, Russo R, Preiser W et al. Acute hepatitis E in Catania (eastern Sicily) 1980-1994. The role of hepatitis E virus. Infection 1997;25:313-16.
57. Chau TN, Lai ST, Tse C et al. Parenteral and sexual transmission are not risk factors for acute hepatitis E infection in Hong Kong [letter]. Am J Gastroenterol 2001;96:3046-7.
58. Emerson SU, Anderson D, Arankalle A et al. Virus taxonomy. In: Fauquet CM, Mayo MA, Maniloff J et al., eds. VIIIth Report of the ICTV. London: Elsevier/Academic Press, 2004:979-96.
59. Kaur M, Hyams KC, Purdy MA et al. Human linear B-cell epitopes encoded by the hepatitis E virus include determinants in the RNA-dependent RNA polymerase. Proc Nat Acad Sci USA 1992;89:3855-8.
60. Yarbough PO, Tam AW, Fry KE et al. Hepatitis E virus: identification of type-common epitopes. J Virol 1991;65:5790-7.
61. Schofield DJ, Purcell RH, Nguyen H et al. Monoclonal antibodies that neutralize HEV recognize an antigenic site at the carboxy terminus of an ORF2 protein vaccine. Vaccine 2003;22:257-67.
62. Zhou Y-H, Purcell RH, Emerson SU. An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. Vaccine 2004;22:2569-76.
63. Meng XJ, Dai X, Chang JC et al. Identification and characterization of the neutralizing epitope(s) of the hepatitis E virus. Virology 2001;288:203-11.
64. Zhang J-Z, Ng MH, Xia NS et al. Conformational antigenic determinants generated by interactions between a bacterial expressed recombinant peptide of the hepatitis E virus structural protein. J Med Virol 2001;64:125-32.
65. Purcell RH, Emerson SU. Hepatitis E virus. In: Knipe D, Howley P, Griffin D et al., eds. Fields Virology. Philadelphia: Lippincott, Williams and Wilkins, 2001:3051-61.
66. Emerson SU, Purcell RH. Recombinant vaccines for hepatitis E (review). Trends Mol Med 2001;7:462-6.
67. Purcell RH. Hepatitis E: prospects for immunoprophylaxis. In: Margolis HS, Alter MJ, Liang TJ, Dienstag JL, eds. Viral Hepatitis and Liver Disease. Proceedings of the 10th International Symposium on Viral Hepatitis and Liver Disease. Atlanta, GA: International Medical Press, 2002:97-102.
68. Armstrong GL, Bell BP. Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics 2002;109:839-45.
69. Bryan JP, Iqbal M, Tsarev S et al. Epidemic of hepatitis E in a military unit in Abbottabad, Pakistan. Am J Trop Med Hyg 2002;67:662-8.
70. Bryan JP, Tsarev SA, Iqbal M et al. Epidemic hepatitis E in Pakistan:patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis 1994;170:517-21.
71. Arankalle VA, Chadha MS, Dama BM et al. Role of immune serum globulins in pregnant women during an epidemic of hepatitis E. J Viral Hepatol 1998;5:199-204.
72. Cao X-Y, Ma X-Z, Liu Y-Z et al. Epidemiological and etiological studies on enterically transmitted non-A, non-B hepatitis in the south part of Xinjiang. In: Shikata T, Purcell RH, Uchida T, eds. Viral Hepatitis C, D, and E. New York: Elsevier Science, 1991:297-312.
73. Joshi MV, Babu S, Sarin S et al. Immunoprophylaxis of epidemic non-A non-B hepatitis. Indian J Med Res 1985;81:18-19.
74. Khuroo MS, Dar MY. Hepatitis E: evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol 1992;11:113-16.
75. Tandon BN, Joshi YK, Jain SK et al. An epidemic of non-A non-B hepatitis in north India. Indian J Med Res 1982;75:739-44.
76. Pillot J, Turkoglu S, Dubreuil P et al. Cross-reactive immunity against different strains of the hepatitis E virus transferable by simian and human sera. CR Acad Sci III 1995;318:1059-64.
77. Tsarev SA, Tsareva TS, Emerson SU et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci USA 1994;91:10198-202.
78. Schofield DJ, Glamann J, Emerson SU et al. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J Virol 2000;74:5548-55.
79. Arankalle VA, Chadha MS, Chobe LP et al. Cross-challenge studies in rhesus monkeys employing different Indian isolates of hepatitis E virus. J Med Virol 1995;46:358-63.
80. Arankalle VA, Chadha MS, Chobe LP et al. Long-term serological follow up and cross-challenge studies in rhesus monkeys experimentally infected with hepatitis E virus. J Hepatol 1999;30:199-204.
81. Bradley DW. Enterically-transmitted non-A, non-B hepatitis. Br Med Bull 1990;46:442-61.
82. Li T-C, Suzaki Y, Ami Y et al. Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles. Vaccine 2004;22:370-7.
83. Tsarev SA, Tsareva TS, Emerson SU et al. Experimental hepatitis E in pregnant rhesus monkeys: failure to transmit hepatitis E virus (HEV) to offspring and evidence of naturally acquired antibodies to HEV. J Infect Dis 1995;172:31-7.
84. Tam AW, White R, Yarbough PO et al. In vitro infection and replication of hepatitis E virus in primary cynomolgus macaque hepatocytes. Virology 1997;238:94-102.
85. Fuerst TR, Yarbough PO, Zhang Y et al. Prevention of hepatitis E using a novel ORF-2 subunit vaccine. In: Buisson Y, Coursaget P, Kane M, eds. Enterically-transmitted Hepatitis Viruses. Joue-les-Tours, France: La Simarre, 1996: 384-92.
86. Anderson DA, Li F, Riddell M et al. ELISA for IgG-class antibody to hepatitis E virus based on a highly conserved conformational epitope expressed in Escherichia coli. J Virol Methods 1999;81:131-42.
87. Dawson GJ, Chau KH, Cabal CM et al. Solid-phase enzymelinked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Methods 1992;38:175-86.
88. Li F, Riddell MA, Seow M et al. Recombinant subunit ORF2.1 antigen and induction of antibody against immunodominant epitopes in the hepatitis E virus capsid protein. J Med Virol 2000;60:379-86.
89. Li F, Torresi J, Locarnini SA et al. Amino-terminal epitopes are exposed when full-length open reading frame 2 of hepatitis E virus is expressed in Escherichia coli, but carboxy-terminal epitopes are masked. J Med Virol 1997;52:289-300.
90. Riddell MA, Li F, Anderson DA. Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies. J Virol 2000;74:8011-17.
91. Li F, Zhuang H, Kolivas S et al. Persistent and transient antibody responses to hepatitis E virus detected by western immunoblot using open reading frame 2 and 3 and glutathione S-transferase fusion proteins. J Clin Microbiol 1994;32:2060-6.
92. Paul DA, Knigge MF, Ritter A et al. Determination of hepatitis E virus seroprevalence by using recombinant fusion proteins and synthetic peptides. J Infect Dis 1994;169:801-6.
93. Purdy MA, McCaustland KA, Krawczynski K et al. Expression of hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates. Arch Virol 1992;123:335-49.
94. Yarbough PO, Tam AW, Gabor K et al. Assay development of diagnostic tests for hepatitis E. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease (Proceedings of the International Symposium on Viral Hepatitis and Liver Disease:Molecules Today, More Cures Tomorrow). New York: Springer-Verlag, 1994:367-70.
95. Im SW, Zhang JZ, Zhuang H et al. A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus. Vaccine 2001;19:3726-32.
96. He J, Tam AW, Yarbough PO et al. Expression and diagnostic utility of hepatitis E virus putative structural proteins expressed in insect cells. J Clin Microbiol 1993;31:2167-73.
97. Li T-C, Yamakawa Y, Suzuki K et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol 1997;71:7207-13.
98. Li T-C, Zhang J, Shinzawa H et al. Empty virus-like particlebased enzyme-linked immunosorbent assay for antibodies to hepatitis E virus. J Med Virol 2000;62:327-33.
99. McAtee CP, Zhang Y, Yarbough PO et al. Purification of a soluble hepatitis E open reading frame 2-derived protein with unique antigenic properties. Protein Expr Purif 1996;8:262-70.
100. McAtee CP, Zhang Y, Yarbough PO et al. Purification and characterization of a recombinant hepatitis E protein vaccine candidate by liquid chromatography - mass spectrometry. J Chromatogr B 1996;685:91-104.
101. Robinson RA, Burgess WH, Emerson SU et al. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr Purif 1998;12:75-84.
102. Tsarev SA, Tsareva TS, Emerson SU et al. ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infec Dis 1993;168:369-78.
103. Xing L, Kato K, Takeda N et al. Recombinant hepatitis E capsid protein self assembles into a dual-domain T = 1 particle presenting native virus epitopes. Virology 1999;265:35-45.
104. Zhang Y, McAtee P, Yarbough PO et al. Expression characterization, and immunoreactivities of a soluble hepatitis E virus putative capsid protein species expressed in insect cells. Clin Diagn Lab Immunol 1997;4:423-8.
105. Torresi J, Li F, Locarnini SA et al. Only the non-glycosylated fraction of hepatitis E virus capsid (open reading frame 2) protein is stable in mammalian cells. J Gen Virol 1999;80:1185-8.
106. Zafrulla M, Ozdener MH, Kumar R et al. Mutational analysis of glycosylation, membrane translocation and cell surface expression of hepatitis E virus ORF2 protein. J Virol 1999;73:4074-82.
107. Tsarev SA, Tsareva TS, Emerson SU et al. Prospects for prevention of hepatitis E. In: Buisson Y, Coursaget P, Kane M, eds. Enterically-Transmitted Hepatitis Viruses (Proceedings of the International Symposium on Enterically-Transmitted Hepatitis Viruses, Paris, France, October 1995). Joué-les-Tours, France: La Simarre, 1996:373-83.
108. Takamura S, Niikura M, Li T-C et al. DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration. Gene Therapy 2004;11:628-35.
109. Yarbough PO, Garza E, Tam AW et al. Assay development of diagnostic tests for IgM and IgG antibody to hepatitis E virus. In: Buisson Y, Coursaget P, Kane M, eds. Enterically-Transmitted Hepatitis Viruses. Joué-les-Tours, France: La Simarre, 1996:294-6.
110. Purdy MA, McCaustland KA, Krawczynski K et al. Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV). J Med Virol 1993;41:90-4.
111. Yarbough PO. Advances in the HEV biology and HEV vaccine approaches. Intervirology 1999;42:179-84.
112. Tsarev SA, Tsareva TS, Emerson SU et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine 1997;15:1834-8.
113. Zhang M, Emerson SU, Nguyen H et al. Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques. Vaccine 2002;20:3285-91.
114. Zhang M, Emerson SU, Nguyen H et al. Immunogenicity and protective efficacy of a vaccine prepared from 53kDa truncated hepatitis E virus capsid protein expressed in insect cells. Vaccine 2002;20:853-7.
115. Li T-C, Takeda N, Miyamura T. Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice. Vaccine 2001;19:3476-84.
116. Nikura M, Takamura S, Kim G et al. Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes. Virology 2002;293:273-80.
117. Ma Y, Lin SQ, Gao Y et al. Expression of ORF2 partial gene of hepatitis E virus in tomatoes and immunoactivity of expression products. World J Gastroenterol 2003;9:2211-15.
118. He J, Binn LN, Caudill JD et al. Antiserum generated by DNA vaccine binds to hepatitis E virus (HEV) as determined by PCR and immune electron microscopy (IEM): application for HEV detection by affinity-capture RT-PCR. Virus Res 1999;62:59-65.
119. He J, Hayes CG, Binn LN et al. Hepatitis E virus DNA vaccine elicits immunologic memory in mice. J Biomed Sci 2001;8:224-6.
120. Che XY, Qian QJ, Liu SX et al. Construction of specifically targeted chimeric hepatitis E virus DNA vaccine and its efficacy assessment. Di Yi Jun Yi Da Xue Xue Bao 2002;22:97-101.
121. Tuteja R, Li T-C, Takeda N et al. Augmentation of immune responses to hepatitis E virus ORF2 DNA vaccination by codelivery of cytokine genes. Viral Immunol 2000;13:169-78.
122. Kamili S, Spelbring J, Krawczynski K. DNA vaccination against hepatitis E virus infection in cynomolgus macaques. J Gastroenterol Hepatol 2002;17:S365-S369.
123. Kamili S, Spelbring J, Carson D et al. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection. J Infect Dis 2004;189:258-64.
124. Purcell RH, Nguyen H, Shapiro M et al. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 2003;21:2607-2615.
125. Safary A. Perspectives of vaccination against hepatitis E. Intervirology 2001;44:162-6.